scholarly journals Alzheimer’s Disease: The Knowledge of Nurses Regarding the Clinical Aspects of the Disease

2018 ◽  
Vol 12 (42) ◽  
pp. 102-110
Author(s):  
Robson Pereira da Silva ◽  
Ivelise Fhrideriad Alves Furtado da Costa
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Survey Research ◽  
Scientific Production ◽  
Integrative Review ◽  
Clinical Aspects ◽  
Professional Conduct ◽  
Electronic Library ◽  
The Subject

Abstract: Objective: To quantify and analyze the scientific production on the knowledge of nurses regarding the etiological, clinical aspects of Alzheimer's disease (AD) and its inherent complications. Methods: this is an integrative review of publications published between 2016 and 2017. The articles analyzed were found by consulting the databases: Scientific Electronic Library Online and Virtual Health Library. We collected 428 articles with the descriptors DA, Nursing, and Diagnosis, 15 of which were selected. Results: predominance of studies addressing the diagnosis but without making reference to clinical aspects of the disease was observed, reinforcing the initial concerns of this survey. Research about this subject does not emphasize all clinical aspects, and the analysis of the knowledge for interventions by nurses is unfeasible. Conclusion: It is essential stay up-to-date to be able to adopt a professional conduct on the subject, directing the care so as to reduce the impacts of the disease.  

scholarly journals The health of elderly people bearing Alzheimer’s disease: an integrative review / Saúde do idoso com doença de Alzheimer: revisão integrativa

2018 ◽  
Vol 10 (4) ◽  
pp. 941
Author(s):  
Hemmily Nóbrega Ventura ◽  
Leila De Cássia Tavares da Fonseca ◽  
Bruno César Fernandes Borges ◽  
Jéssica Yasmine Lacerda Nóbrega ◽  
Herbert Nóbrega Ventura ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Elderly People ◽  
Integrative Review

Objetivo: Verificar o conhecimento produzido pelos pesquisadores a respeito da saúde do idoso com Doença de Alzheimer (DA). Métodos: Revisão integrativa da literatura com levantamento bibliográfico realizado na Biblioteca Virtual em Saúde (BVS), MEDLINE e nos bancos de dados do Portal de Periódicos Capes.  Resultados: Observou-se a incipiência de artigos científicos publicados sobre a Doença de Alzheimer com enfoque na saúde da pessoa idosa. Conclusão: Verificou-se a necessidade de pesquisas para investigar a saúde do idoso em face à doença de Alzheimer que possibilitem aporte teórico na elaboração de políticas públicas de saúde mais abrangentes para os cuidados aos idosos. Descritores: Envelhecimento, Doença de Alzheimer, Autonomia pessoal, Saúde do idoso.

scholarly journals Working Memory and the Enactment Effect in Early Alzheimer’s Disease

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Lara A. Charlesworth ◽  
Richard J. Allen ◽  
Suzannah Morson ◽  
Wendy K. Burn ◽  
Celine Souchay
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Working Memory ◽  
Free Recall ◽  
Older Adult ◽  
Memory Task ◽  
Enactment Effect ◽  
The Subject ◽  
Instruction Sequences ◽  
Early Alzheimer’S Disease

This study examines the enactment effect in early Alzheimer’s disease using a novel working memory task. Free recall of action-object instruction sequences was measured in individuals with Alzheimer’s disease (n=14) and older adult controls (n=15). Instruction sequences were read out loud by the experimenter (verbal-only task) or read by the experimenter and performed by the participants (subject-performed task). In both groups and for all sequence lengths, recall was superior in the subject-performed condition than the verbal-only condition. Individuals with Alzheimer’s disease showed a deficit in free recall of recently learned instruction sequences relative to older adult controls, yet both groups show a significant benefit from performing actions themselves at encoding. The subject-performed task shows promise as a tool to improve working memory in early Alzheimer’s disease.

Technological prospecting of music therapy in Alzheimer's disease

2021 ◽  
Vol 10 (16) ◽  
pp. e443101622316
Author(s):  
Murilo Bastos ◽  
Kelby Cavalheiro de Mendonça ◽  
Valquiria Camargo Lins ◽  
Eduardo Muzzolon ◽  
Deise Mara Soares ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Music Therapy ◽  
Memory Loss ◽  
Active Therapy ◽  
Pharmacological Interventions ◽  
Limited Efficacy ◽  
Drug Treatments ◽  
The Subject

Alzheimer's disease (AD) is characterized by cognitive impairment and progressive memory loss and drug treatments have limited efficacy. Thus, non-pharmacological interventions, such as music therapy, have shown to be promising as supporting pharmacological treatment and, therefore, may arouse commercial interest regarding the development of this type of product. Thus, this study aims to carry out a patentometric survey on patent registrations with music therapy in the treatment of AD. A systematic search was carried out from 2000 to 2020 on the Orbti-Questel website, searching for documents referring to music therapies in AD. The terms “Alzheimer music methodology active therapy” and “Alzheimer music methodology passive therapy” were used. After searching, reading, and excluding duplicate results, we found four patent families referring to music therapy in AD and all were selected as a result, which was considered little compared to the number of studies published on the subject.

Nutritional Interventions for Persons With Early-Stage Dementia or Alzheimer's Disease: An Integrative Review

2019 ◽  
Vol 12 (5) ◽  
pp. 259-268 ◽  
Author(s):  
Ingelin Testad ◽  
Martine Kajander ◽  
Christina Tolbol Froiland ◽  
Anne Corbett ◽  
Martha T. Gjestsen ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Early Stage ◽  
Integrative Review ◽  
Nutritional Interventions

scholarly journals Action of anti-TNF-α drugs on the progression of Alzheimer's disease: A case report

2015 ◽  
Vol 9 (2) ◽  
pp. 196-200 ◽  
Author(s):  
Carlos Henrique Ferreira Camargo ◽  
Filipe Fernandes Justus ◽  
Giuliano Retzlaff ◽  
Marcelo Rezende Young Blood ◽  
Marcelo Derbli Schafranski
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Drug Class ◽  
Cognitive Response ◽  
Cognitive Improvement ◽  
Tnf Α ◽  
Patient Reported ◽  
Previously Treated ◽  
The Subject

The aim of this study was to describe a clinical case of a patient with Alzheimer's disease (AD) in use of an anti-TNF-α agent for rheumatoid arthritis (RA). The patient reported is an 81-year-old Caucasian man and retired teacher, diagnosed with RA in 2008 and AD in 2011. Treatment with donepezil was started in 2011 and the use of etanercept introduced in 2012. He was previously treated with adalimumab in 2010 for 18 months. In 2013, the subject was engaged in a clinical trial to assess a complementary non-pharmacological approach for AD, presenting significant cognitive improvement during the follow-up period. We propose the hypothesis of a synergistic effect of anti-TNF-α medication used for the treatment of RA as the cause of the improvement in cognitive response observed. These findings could suggest a possible use of this drug class in the therapeutic management of AD.

Clinical aspects of Alzheimer’s disease

2001 ◽  
Vol 13 (3) ◽  
pp. 221-230 ◽  
Author(s):  
A. Bianchetti ◽  
M. Trabucchi
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Aspects

Rationale for combination therapy with galantamine and memantine in alzheimer’s disease: the efficacy of treatment of addition

2011 ◽  
Vol 26 (S2) ◽  
pp. 507-507
Author(s):  
J. Zarra
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Adverse Events ◽  
Well Being ◽  
Disease Assessment ◽  
Clinical Aspects ◽  
Neurocognitive Disorder ◽  
Clinical Dementia Rating ◽  
Open Label ◽  
Behavioural Symptoms

ObjectiveThe efficacy, safety, and tolerability of nootropic cholinergic agent: GALANTAMINE (with a dual mechanism of action on the cholinergic a system) and moderate affinity NMDA- receptor antagonist: MEMANTINE, were assessed taking into account the profile of patients with neurocognitive disorder: Alzheimer's disease, from the clinical aspects and the different classifications.MethodsThe experience included 428 patients who were enrolled in a prospective, observational, multicenter, and open-label study to receive 16 mg/day of galantamine and 30 mg/day of memantine for 12 months of treatment of addition.ResultsThe therapeutic response was measured using the Mini Mental State Examination (MMSE), Clinical Dementia Rating (CDR), Alzheimer's Disease Assessment Scale (ADAS-GOG), Functional Activities Questionnaire(FAQ) the Clinical Global Impression Scale (CGI) and the UKU scale of adverse effectstaking into account the efficacy, safety and adverse events of the treatment.The final results of the study showed that galantamine with addition memantine improves cognition, behavioural symptoms, and the general well-being of patients with cognitive impairment: Alzheimer's disease. The incidence of adverse events was not significant and a very good profile of tolerability and safety was observed.ConclusionAt the conclusion of this session, the participant should be able to demonstrate with use the association memantine - galatamine in neurocognitive disorder: Alzheimer's disease, improve cognition, behavioural symptoms, and the general state recognized as neurocognitive disorder.

Sign in / Sign up

Export Citation Format

Share Document